Navigation Links
New NAPHS Annual Survey Tracks Behavioral Treatment Trends
Date:5/16/2008

WASHINGTON, May 16 /PRNewswire-USNewswire/ -- Behavioral healthcare systems are playing a major role in responding to the needs of the millions of Americans of all ages who experience psychiatric and substance use conditions each year, according to the latest annual survey from the National Association of Psychiatric Health Systems (NAPHS) released today.

The 2007 NAPHS Annual Survey provides two distinct views of behavioral healthcare delivery. One chapter provides a trend analysis that looks at changes from year to year in hospitals and residential treatment centers reporting over a two-year period. Another chapter provides a snapshot of all members' experiences in 2006. This chapter also presents selected data by set-up-and-staffed bed categories to help organizations compare their own experiences to those of facilities of a similar size.

Trend analysis shows strong demand for behavioral health services. Inpatient hospital admissions, for example, increased 3.4% from 2005 to 2006 (to an average of 2,557) in facilities reporting in both years. Hospital lengths of stay remained steady at 9.6 days in both 2005 and 2006. Trended residential treatment admissions increased 2.3% in the same time frame (to an average of 175).

The survey also demonstrates great diversity of services, levels of care, and payer sources for children, adolescents, adults, and older adults experiencing mental and substance use disorders. In addition to hospital-level care, NAPHS-member facilities provide residential care, partial hospitalization, and outpatient care. These facilities also offer a comprehensive array of community services, including substance use services, special education, housing, and case management. Payer sources include Medicaid, Medicare, private insurance, state governments, and others such as juvenile justice systems.

The report is $400--prepaid. Call 202/393-6700, ext. 106, for ordering information or see

SOURCE National Association of Psychiatric Health Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
2. IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
3. Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
4. SCAI announces 2009 annual scientific sessions in Las Vegas
5. Golden Rainbow Takes a Musical Journey for Its 22nd Annual Ribbon of Life Production Show
6. SXC Health Solutions to present at the FBR Capital Markets 12th Annual Spring Investor Conference
7. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
8. The Canary Foundation Announces Its Fourth Annual Early Detection Symposium
9. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
10. BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
11. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...re receiving MMR shots, say official figures.// ... of two-year-olds were given the jab, which protec...the national target of 95 per cent. Yet, this i... previous year, when the figure was 89.9 per cent....
...s published in The Lancet on adolescent health, th...when compared to their parents.// The infections o...ve given way to venereal diseases, drinking, smoki...y silver lining to this issue is that these condit...
...e it worse. New research links them to three time... Claiming to be the world’s first such research, ...say that overweight girls triple their risk of dev... The findings published in the European Respirato...
...ed the aerated drink manufacturers Pepsico and Coc...ports.// The Ganguly report had deduced that pesti... from Pepsico and Coca cola should be furnished wi...rest, a civil society group had filed a public int...
Other Medicine News:Health News:Scotland’s Parents Still a Little Wary of MMR Shot 2Health News:Chubby Cute Little Girls- Not for the Health Conscious 2
(Date:7/21/2008)...e news release, "Update on the SEAS Study" issued ...EAS Study Principal Investigator & Head,of Steerin...representative,of the organisation that the follow... Satellite coordinates, audio access and URL for ....5 Deg West Txp: B6 Lower, Channel 2 DL: 11152.7...
(Date:7/21/2008)...iled lipid profile helps clinicians identify risk ...ormal LDL levels and statin therapy, BIRMINGHAM, ...terol,Test from Atherotech, researchers have ident... progression. The information could help,physician...l and heart,disease risk-lowering treatments in at...
(Date:7/21/2008)...IEGO, July 21 /- Bioimpedance spectro...er methods of subclinical assessment of,lymphedema...ublished in the,July 20 issue of Journal of Clinic..., Titled "Lymphedema After Breast Cancer: Inciden...n," the paper, authored by Sandra Hayes, PhD.,and...
(Date:7/21/2008)...N, July 21 /- Professor Terje Pederse...d investigator for the Simvastatin,and Ezetimibe i...date on,the study on Monday the 21st July., Also ...sor of Medical,Statistics and Epidemiology and Co-...ersity of Oxford) Professor Rory Collins (BHF Prof...
Breaking Medicine Technology:/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/ 2/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/ 3VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona Based Biotech Companies 6228 1ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona Based Biotech Companies 6228 2New Vaccine May Account for Less Severe Rotavirus Season 22803 1New Vaccine May Account for Less Severe Rotavirus Season 22803 2CBO 3A Biogenerics Would Save Federal Government 246 6 Billion Over Ten Years 6223 1CBO 3A Biogenerics Would Save Federal Government 246 6 Billion Over Ten Years 6223 2ABT is the Only Source for Kelo cote 28R 29 Advanced Formula Scar Gel 6220 1
...Data Show Bifeprunox Maintained Stability,Signific...ht and,Lipid Profile Comparable with Placebo , MAR...olvay,Pharmaceuticals, Inc., Wyeth Pharmaceuticals... presented clinical study results on,bifeprunox, a...gnosed with schizophrenia, today at the 2007 annua...
...d To Support FDA Approval of SEROQUEL XR--, WILMIN...,AstraZeneca today announced that two analyses fro...cy of SEROQUEL XR(TM) (quetiapine,fumarate) Extend...treatment of schizophrenia in adult patients, were...ican Psychiatric Association,(APA). These analyses...
Other Medicine Technology:New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: